Since the hematopoietic progenitor marker CD34 (51) was downregulated by both OTs and MYB knockdown, this suggests that the differentiation seen following OT treatment is, at least partly, mediated by decreased MYB expression in T-ALL cells. The gene discussed is CD34; the disease is acute lymphoblastic leukemia.